This initial study did not examine doses, compliance issues, or severity of symptoms, nor did it examine specific psychotropics other than cholinesterase inhibitors.

• 研究一开始时并未检验剂量、顺应性、或是症状严重度，也未检验胆碱酯酶抑制剂以外的特定精神病药物；